Launchpad12 LLC offered to acquire remaining 81.99% stake in Gene Techno Science Co., Ltd. (TSE:4584) from DyDo DRINCO, INC., Japan Securities Finance Co. Ltd., Asset Management Arm, SBI Holdings Inc., Asset Management Arm, Senju Pharmaceutical Co.,Ltd. and others for ¥11.1 billion on March 28, 2016. Under the terms, Noritsu Koki offered a takeover bid for 3.72 million shares of Gene Techno Science at ¥3000 per share. In a related deal, Gene Techno Science passed a resolution to conduct an issuance of new shares towards Launchpad12 LLC by third-party allocation. Post-acquisition, Noritsu Koki's stake in Gene Techno Science will increase to 100% from 18.01%. Offering period starts from April 15, 2016 to May 30, 2016 and settlement will start on June 6, 2016.

Yamada FAS Co., Ltd. acted as financial advisor and Abe, Ikubo & Katayama acted as legal advisor for Gene Techno Science and Abe, Ikubo and Katayama as legal advisor for fairness and rationality of decision-making processes and methods. Nomura Securities Co., Ltd. acted as tender offer agent in the transaction. Plutus Consulting Co., Ltd. acted as valuer for Launchpad12 LLC.